|
|
Other links at Articles > Pharmacists |
| 2. |
Chemotherapy and Tamoxifen Cut Long-Term Risk of Contralateral Breast Cancer
|
|
|
Adjuvant chemotherapy and tamoxifen treatment for primary breast cancer are both independently associated with reduced risks of contralateral breast cancer that persist for up to 10 and 5 years, respectively, after the first cancer diagnosis, according to a report in the Journal of the National Cancer Institute for January 2. Reuters Health Information
|
|
|